Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Function in Achilles Tendon Disorders

March 2, 2026 updated by: University of Brasilia

Immediate Effects of Neuromuscular Electrical Stimulation on Pain and Functional Performance in Individuals With Achilles Tendinopathy and Tendon Rupture: A Randomized Crossover Clinical Trial

The Achilles tendon exhibits high tensile strength and can withstand extremely high loads. However, it is susceptible to injuries such as tendinopathies and ruptures, which are associated with structural alterations and loss of function. Strategies have been investigated to enhance clinical rehabilitation. Nevertheless, the effects of neuromuscular electrical stimulation on pain and functional improvement, as well as the optimal dosing parameters for the rehabilitation of Achilles tendon injuries, remain inconclusive. The aim of this study is to compare the immediate effects of two electrical stimulation protocols on pain, functional performance, peripheral oxygen extraction, and maximal tendon displacement during a single leg heel rise functional task in patients with Achilles tendinopathy and/or a history of Achilles tendon rupture. In addition, this study aims to characterize Achilles tendon structural properties and ankle plantarflexor muscle strength in this population.

Study Overview

Detailed Description

All groups will be composed of participants with a primary complaint of pain and/or a history of previous Achilles tendon rupture. Participants will perform the interventions in two blocks separated by a seven-day interval (wash-out). Block A: (1) control without active intervention and (2) electrical stimulation applied at the maximum tolerated intensity. Block B: (3) control with sham stimulation and (4) sensory-level electrical stimulation. Block A will always be performed first, followed by Block B. Interventions within each block will be conducted in three sets of 10 repetitions, totaling six sets per day.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Federal District
      • Brasília, Federal District, Brazil, 72220900

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primary complaint of pain localized in the midportion (2-6 cm proximal to the calcaneus) or insertion of the Achilles tendon, and/or a history of Achilles tendon rupture occurring at least 3 months prior to assessment.
  • Pain on palpation of the Achilles tendon.
  • Pain during load-bearing activities

Exclusion Criteria:

  • Exclusive diagnosis of bursitis confirmed by ultrasonographic assessment
  • Any other lower limb injury
  • History of lower limb surgery within the past year
  • Previous Achilles tendon tenoplasty performed less than 3 months prior to assessment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control without active intervention
In this group, participants will perform three sets of 10 repetitions of the single leg heel rise functional task without the application of electrical stimulation. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.
Experimental: Electrical stimulation applied at the maximum tolerated intensity
Under this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed electrical stimulation applied at the maximum tolerated intensity, characterized by visible muscle contraction and associated with a self-reported discomfort level between 8 and 10 on the Numeric Rating Scale. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.
Neuromuscular electrical stimulation-induced contractions will be delivered using an electrical stimulator connected to a pair of 5×5 cm self-adhesive surface electrodes. Stimulation will be applied in a superimposed manner during voluntary movement, at a frequency of 75 Hz and a phase duration of 400 µs.
Placebo Comparator: Control with sham stimulation
For this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed sham electrical stimulation. Electrical stimulation parameters will initially be configured identically to those used in the active intervention. However, to ensure adequate blinding, stimulation will be applied for approximately 40 seconds and then gradually reduced until complete cessation. From this point onward, no additional current will be delivered, although the device will remain on and the electrodes will remain in place throughout the test. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.
Neuromuscular electrical stimulation-induced contractions will be delivered using an electrical stimulator connected to a pair of 5×5 cm self-adhesive surface electrodes. Stimulation will be applied in a superimposed manner during voluntary movement, at a frequency of 75 Hz and a phase duration of 400 µs.
Active Comparator: Sensory-level electrical stimulation
In this condition, participants will perform three sets of 10 repetitions of the single leg heel rise functional task with superimposed electrical stimulation applied at the sensory level, defined as the highest intensity that does not elicit visible muscle contraction. Immediately after each set, pain level, functional performance, peripheral oxygen extraction, and maximal Achilles tendon displacement will be assessed.
Neuromuscular electrical stimulation-induced contractions will be delivered using an electrical stimulator connected to a pair of 5×5 cm self-adhesive surface electrodes. Stimulation will be applied in a superimposed manner during voluntary movement, at a frequency of 75 Hz and a phase duration of 400 µs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain level
Time Frame: Immediately after the performance of the functional task
Pain intensity during the single leg heel rise task will be assessed using the Visual Analog Scale, consisting of a numerical scale ranging from 0 to 10 points, in which 0 represents no pain and 10 corresponds to the worst pain ever experienced by the participant.
Immediately after the performance of the functional task

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total time
Time Frame: Immediately after the performance of the functional task.
The total time (s) during the single-leg heel rise task will be measured using the MuscleLab® system.
Immediately after the performance of the functional task.
Maximal displacement
Time Frame: Immediately after the performance of the functional task.
The maximal displacement (cm) during the single-leg heel rise task will be measured using the MuscleLab® system.
Immediately after the performance of the functional task.
Total work
Time Frame: Immediately after the performance of the functional task.
The total work (J) during the single-leg heel rise task will be measured using the MuscleLab® system.
Immediately after the performance of the functional task.
Total power
Time Frame: Immediately after the performance of the functional task.
The total power (W) during the single-leg heel rise task will be measured using the MuscleLab® system.
Immediately after the performance of the functional task.
Number of repetitions
Time Frame: Immediately after the performance of the functional task.
The number of repetitions completed during the single-leg heel rise task will be recorded using the MuscleLab® system.
Immediately after the performance of the functional task.
Peripheral oxygen extraction
Time Frame: Immediately after the performance of the functional task.
Oxygen extraction of the periarticular ankle muscles will be assessed using near-infrared spectroscopy, with the sensor positioned on the skin over the lateral gastrocnemius muscle during the single leg heel rise task. Variations in oxy- and deoxy-hemo/myoglobin (O₂Hb and HHb, respectively) will be recorded in arbitrary units at a sampling frequency of 25 Hz.
Immediately after the performance of the functional task.
Maximal Achilles tendon displacement
Time Frame: Immediately after the performance of the functional task.
Maximal Achilles tendon displacement (%) will be measured using a transducer positioned over the myotendinous junction of the gastrocnemius muscles, secured to a specific support, during the single leg heel rise task. Maximal displacement will be determined based on the change in Achilles tendon length relative to its resting length.
Immediately after the performance of the functional task.
Lenght of achilles tendon
Time Frame: Baseline (prior to Block A only)
The total and free length (cm) of the Achilles tendon will be measured using portable ultrasonography.
Baseline (prior to Block A only)
Thickness of achilles tendon
Time Frame: Baseline (prior to Block A only)
The thickness (mm) of the Achilles tendon will be measured using portable ultrasonography.
Baseline (prior to Block A only)
Cross-sectional area of achilles tendon
Time Frame: Baseline (prior to Block A only)
The cross-sectional area (cm²) of the Achilles tendon will be measured using portable ultrasonography.
Baseline (prior to Block A only)
Presence of neovascularization of the Achilles tendon
Time Frame: Baseline (prior to Block A only)
The presence of neovascularization of the Achilles tendon will be assessed using portable ultrasonography.
Baseline (prior to Block A only)
Elastic modulus
Time Frame: Baseline (prior to Block A only)
The median elastic modulus (kPa) of the Achilles tendon will be measured using shear wave elastography.
Baseline (prior to Block A only)
Shear wave velocity
Time Frame: Baseline (prior to Block A only)
The median shear wave velocity (m/s) of the Achilles tendon will be measured using shear wave elastography.
Baseline (prior to Block A only)
Depth
Time Frame: Baseline (prior to Block A only)
The measurement depth (cm) of the Achilles tendon during elastography assessment will be recorded using shear wave elastography.
Baseline (prior to Block A only)
Isometric strength
Time Frame: Baseline (prior to Block A only)
Isometric strength will be assessed using an isokinetic dynamometer, based on peak isometric torque (N/m) during plantar flexion at 0°.
Baseline (prior to Block A only)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 6, 2026

Primary Completion (Estimated)

August 30, 2029

Study Completion (Estimated)

December 30, 2029

Study Registration Dates

First Submitted

February 13, 2026

First Submitted That Met QC Criteria

March 2, 2026

First Posted (Actual)

March 6, 2026

Study Record Updates

Last Update Posted (Actual)

March 6, 2026

Last Update Submitted That Met QC Criteria

March 2, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Achilles Tendon Rupture

Clinical Trials on Neuromuscular Electrical Stimulation (NMES)

Subscribe